any human use for muscle growth occurs off-label and outside FDA-reviewed clinical protocols
It is pivotal, however, that the exact concentration of LC-FFA that the -cells are exposed to is determined as without this knowledge it cannot be inferred whether lipotoxicity is relevant to the human condition
The translation pipeline (Figure 3) typically progresses from identifying a promising metabolite or herbal formula, demonstrating efficacy in cellular and animal models, ensuring quality control in formulation, conducting early-phase human safety studies, then larger efficacy trials, and finally seeking guideline inclusion if successful
This is where the conversation around innovative research compounds like BPC-157 becomes incredibly relevant
Yasufuku T, Shigemura K, Shirakawa T, et al